The Acute Myeloid Leukemia Channel is supported through an educational grant from Jazz Pharmaceuticals.
The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
SOHO 2026 | Referral and transplant-timing decisions in AML: advice for community physicians
Iskra Pusic, MD, MSCI, Washington University School of Medicine, St. Louis, MO, shares advice for community physicians on referral and transplant-timing decisions for patients with acute myeloid leukemia (AML). Dr Pusic emphasizes the importance of early referral and risk stratification in enabling timely molecular testing and informing treatment decisions. This interview took place at the 14th Annual Meeting of the Society of Hematologic Oncology (SOHO 2026) in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
